Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + esketamine versus propofol + alfentanil for sedation during ERCP
NL-OMON45146Active, not recruiting
- Sponsor
- Department of Anesthesiology and , Department of Gastroenterology & Hepatology, Academic Medical Centre,
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in None comparing Propofol + esketamine with Propofol + alfentanil (2 arms). Primary endpoints: Total propofol dosage, Adequacy of sedation and analgesia and 3 more. Started Dec 2015; status: active, not recruiting.
02
Drugs
propofolesketaminealfentanil
Beyond the preview
Go deeper on NL-OMON45146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45146.